Previous 10 | Next 10 |
2024-01-27 16:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-08 08:31:52 ET Summary The healthcare sector was flat in 2023 year as a result of some unique issues. Drug price regulation will be a serious challenge for the sector this year. Defensive healthcare industry groups should do well during the first half and biotechnology...
RANCHO CUCAMONGA, CA / ACCESSWIRE / January 2, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Dr. Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the 42 nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 at 9:00 am PST...
2023-12-21 15:26:31 ET Summary Today, we look at generic drug concern Amphastar Pharmaceuticals, Inc., whose stock has more than doubled over the past year. The company also made a major acquisition this spring, but insider selling did pick up in November. What's ahead for Amp...
2023-11-21 11:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 20, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, S.V.P. of Corporate Communications, will participate in an Analyst-Moderated fireside chat at the Piper Sandler 35 th Annual Healthcare C...
2023-11-17 15:03:18 ET More on Amphastar Pharmaceuticals Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2023 Earnings Call Transcript Amphastar Pharmaceuticals: Great Growth At A High Price Amphastar: Dip, But No Slip, Rebound Playbook (Rating Upgrade) Amphastar P...
2023-11-15 17:36:04 ET More on Amphastar Pharmaceuticals Amphastar Pharmaceuticals: Great Growth At A High Price Amphastar: Dip, But No Slip, Rebound Playbook (Rating Upgrade) Amphastar Pharmaceuticals Q3 2023 Earnings Preview Amphastar Pharmaceuticals prices...
2023-11-08 22:39:05 ET Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2023 Earnings Conference Call November 08, 2023, 05:00 PM ET Company Participants Dan Dischner - SVP of Corporate Communications Bill Peters - CFO Conference Call Participants Glen Santangel...
2023-11-08 17:22:15 ET Amphastar Pharmaceuticals press release ( NASDAQ: AMPH ): Q3 Non-GAAP EPS of $1.15 beats by $0.46 . Revenue of $180.6M (+50.3% Y/Y) beats by $6.8M . For further details see: Amphastar Pharmaceuticals Non-GAAP EPS of $1.15 beats by $...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
The Federal Trade Commission (FTC) is intensifying its efforts to challenge numerous pharmaceutical patent listings, aiming to facilitate...
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 30, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2024 ended March 31, 2024, after the market closes on Wednesday, May 8, 2024, and will hold a conference call to discuss its...
2024-04-29 08:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...